Their activity as cationic photoinitiators was studied using real-time infrared spectroscopy. The results obtained showed that PhCH2PhFe+CpPF6- and PhCOPhFe+CpPF6- are capable of photoinitiating the cationic polymerization of epoxy monomer directly on irradiation with long-wavelength UV light. Comparative studies also demonstrated that PhCH2PhFe+CpPF6- exhibited better efficiency than I-261 and PhCOPhFe+CpPF6-. DSC studies showed that PhCOPhFe+CpPF6- and PhCH2PhFe+CpPF6- photoinitiators in epoxides possess good thermal

stability in the absence of light. (C) 2008 Elsevier B.V. All rights reserved.”
“Objective To assess the safety and efficacy of tetrahydrobiopterin therapy with sapropterin to treat tetrahydrobiopterin (BH4)-responsive

HDAC inhibitor phenylalanine hydroxylase (PAH) deficiency in children aged smaller than 4 years compared with those aged bigger than = 4 years. Study design We analyzed a longitudinal follow-up study conducted in all patients with BH4-responsive PAH deficiency throughout Japan. At the end of 2011, 43 patients were receiving sapropterin, of whom 21 were aged smaller than 4 years at the initiation of treatment. The starting dose of sapropterin was bigger than = 10 mg/kg/day in 11 of these 21 patients. find more The duration of follow-up was bigger than = 4 years in 6 of those 11 patients; 3 of these 6 were followed for bigger than = 10 years. Nine patients were receiving sapropterin monotherapy at the end of 2011. Results Serum phenylalanine level was maintained within the recommended optimal control range in all SN-38 21 patients who started sapropterin treatment before age 4 years. Only 1 nonserious adverse drug reaction

occurred, an elevated alanine aminotransferase level in 1 patient. No significant abnormal behavior related to nerve disorders was reported. Conclusion Sapropterin therapy initiated before age 4 years was effective in maintaining serum phenylalanine level within the favorable range and was safe in Japanese patients with BH4-responsive PAH deficiency.”
“Although usually assumed to be smooth and continuous, mammalian cochlear frequency-position maps are predicted to manifest a staircase-like structure comprising plateaus of nearly constant characteristic frequency separated by abrupt discontinuities. The height and width of the stair steps are determined by parameters of cochlear frequency tuning and vary with location in the cochlea. The step height is approximately equal to the bandwidth of the auditory filter (critical band), and the step width matches that of the spatial excitation pattern produced by a low-level pure tone. Stepwise tonotopy is an emergent property arising from wave reflection and interference within the cochlea, the same mechanisms responsible for the microstructure of the hearing threshold.